Synthetic cannabinoids (SC) have exploded on to the scene. With this rise in SC use,
the number of complications and potential adverse effects are also well documented
in the literature and is on the rise. The most frequently cited side effects are behavioral
in nature and range for severe agitation to psychosis and delirium. We report a case
of hyperthermia with severe rhabdomyolysis from SC use.
To read this article in full you will need to make a payment
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D; use, select 'Corporate R&D; Professionals'
Subscribe:
Subscribe to The American Journal of Emergency MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- An outbreak of exposure to a novel synthetic cannabinoid.N Engl J Med. 2014; 370: 389-390
- The rise in K2 use with varying clinical symptoms and the potential for ED crowding.Am J Emerg Med. 2015; 33: 582
- Spice/K2 drugs–more than innocent substitutes for marijuana.Int J Neuropsychopharmacol. 2014; 17 ([PMID:24169044]): 509-525
- Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.Drug Alcohol Depend. 2014; 144 ([PMID:25220897]): 12-41
- “Spice” and “K2” herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans.Am J Addict. 2012; 21 ([PMID: 22691010]): 320-326
- Rosen's emergency medicine: concepts and clinical practice.978-0-323-02845-5 Mosby/Elsevier, 2006: 2388
- K2 types and their contents: are product disclosures true?.Am J Emerg Med. 2015; 33: 845-846
Article Info
Publication History
Published online: June 13, 2015
Accepted:
May 26,
2015
Received:
May 7,
2015
Identification
Copyright
© 2015 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
